FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1424901000168104: polatuzumab vedotin (AU substance)


Status: current, Primitive. Date: 31-Dec 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4286121000168116 polatuzumab vedotin (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4286131000168118 polatuzumab vedotin en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
polatuzumab vedotin Is a medicinal substance true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
polatuzumab vedotin has intended active ingredient True polatuzumab vedotin Inferred relationship Some 330152567
Polivy 140 mg powder for injection, 140 mg vial has Australian BoSS True polatuzumab vedotin Inferred relationship Some 117775679
Polivy 140 mg powder for injection, 140 mg vial has intended active ingredient True polatuzumab vedotin Inferred relationship Some 117775679
polatuzumab vedotin 140 mg injection, vial has intended active ingredient True polatuzumab vedotin Inferred relationship Some 661471325
polatuzumab vedotin 140 mg injection, vial has Australian BoSS True polatuzumab vedotin Inferred relationship Some 661471325
Polivy 30 mg powder for injection, 30 mg vial has intended active ingredient True polatuzumab vedotin Inferred relationship Some 501270061
Polivy 30 mg powder for injection, 30 mg vial has Australian BoSS True polatuzumab vedotin Inferred relationship Some 501270061
polatuzumab vedotin 30 mg injection, vial has Australian BoSS True polatuzumab vedotin Inferred relationship Some 149572807
polatuzumab vedotin 30 mg injection, vial has intended active ingredient True polatuzumab vedotin Inferred relationship Some 149572807

This concept is not in any reference sets

Back to Start